Dr. Sadoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
U of MN Med Sch, Minneapolis
Minneapolis, MN 55455
Education & Training
University of Minnesota Medical SchoolClass of 1968
Certifications & Licensure
MN State Medical License 1969 - 2019
Publications & Presentations
PubMed
- 21 citationsSafety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized TrialRichard N. van Zyl-Smit, Aliasgar Esmail, Mary Bateman, Rodney Dawson, Jonathan G. Goldin
American Journal of Respiratory and Critical Care Medicine. 2017-05-01 - 199 citationsSystems analysis of protective immune responses to RTS,S malaria vaccination in humansDmitri Kazmin, Helder I. Nakaya, Eva K. Lee, Matthew Johnson, Robbert van der Most
Proceedings of the National Academy of Sciences of the United States of America. 2017-02-28 - 16 citationsAdenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine.Melissa Nyendak, Gwendolyn Swarbrick, Amanda Duncan, Meghan E. Cansler, Ervina Winata Huff
Scientific Reports. 2016-11-02
Journal Articles
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 VaccineJerald Sadoff, Kathryn E Stephenson, Dan H Barouch, Macaya Douoguih, The New England Journal of Medicine
Press Mentions
Single-Dose Ad26.COV2.S Effective Against COVID-19April 26th, 2021- No Causal Link Found so Far Between J&J's Covid-19 Vaccine and Blood-Clot Cases, Company Researchers SayApril 16th, 2021
- Ad26.COV2-S Vaccine Seems Safe, Immunogenic for SARS-CoV-2January 14th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
